Young Kwon

2018

In 2018, Young Kwon earned a total compensation of $2.4M as Chief Business Officer at Momenta Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$202,400
Salary$411,796
Stock Awards$1,742,100
Other$13,378
Total$2,369,674

Kwon received $1.7M in stock awards, accounting for 74% of the total pay in 2018.

Kwon also received $202.4K in non-equity incentive plan, $411.8K in salary and $13.4K in other compensation.

Rankings

In 2018, Young Kwon's compensation ranked 4,903rd out of 14,244 executives tracked by ExecPay. In other words, Kwon earned more than 65.6% of executives.

ClassificationRankingPercentile
All
4,903
out of 14,244
66th
Division
Manufacturing
1,841
out of 5,759
68th
Major group
Chemicals And Allied Products
673
out of 2,122
68th
Industry group
Drugs
563
out of 1,811
69th
Industry
Biological Products, Except Diagnostic Substances
114
out of 339
66th

Pay ratio

Young Kwon's Pay$2,369,674
Median Employee's Pay$175,536
Pay Ratio

13

to 1

In 2018, the annual total compensation of Young Kwon was $2,369,674.

The annual total compensation of the median employee at Momenta Pharmaceuticals was $175,536.

The ratio of Young Kwon's pay to the pay of median employee was therefore 13 to one.

Source: SEC filing on April 26, 2019.

Kwon's colleagues

We found five more compensation records of executives who worked with Young Kwon at Momenta Pharmaceuticals in 2018.

2018

Craig Wheeler

Momenta Pharmaceuticals

Chief Executive Officer

2018

Santiago Arroyo

Momenta Pharmaceuticals

Chief Medical Officer

2018

Anthony Manning

Momenta Pharmaceuticals

Chief Scientific Officer

2018

Scott Storer

Momenta Pharmaceuticals

Chief Financial Officer

2018

Michelle Robertson

Momenta Pharmaceuticals

Chief Financial Officer

News

You may also like